Skip to main content

Government officials will never ask you to transfer money or disclose bank log-in details over a phone call.

Call the 24/7 ScamShield Helpline at 1799 if you are unsure if something is a scam.

Agency for Care Effectiveness
  1. Home
  2. Healthcare professionals
  3. ACE Technology Guidances
  4. Drug Guidance
  5. Ixekizumab and secukinumab for treating active ankylosing spondylitis
Withdrawn

Ixekizumab and secukinumab for treating active ankylosing spondylitis

Condition

Musculoskeletal

Blood and Immune System

31 August 2022

Published on 03 Aug 2021
Last Updated on 31 Aug 2022

Ixekizumab and secukinumab for treating active ankylosing spondylitis Guidance is outdated and has been withdrawn on 31 August 2022. The Plain English Summary (PES) has been updated on 31 August 2022.

Ixekizumab and secukinumab for treating active ankylosing spondylitis PES (Updated-31 Aug 22) [PDF, 176 KB]

Ixekizumab and secukinumab for treating active ankylosing spondylitis (Withdrawn 31 Aug 22) [PDF, 76 KB]

Back to top